Sign In
Buy NVAX
$10.20
-0.0100 (-0.0979%)
At Close: Jun 03, 2026
Australia reaches 95% first-dose vaccination rate but Covid deaths continue to climb
02:04am, Saturday, 15'th Jan 2022 The Guardian
Greg Hunt says decision on Novavax vaccine expected by Therapeutic Goods Administration in the coming 10 days
Novavax Still Has Not Received an FDA EUA as the Market Waits
08:35pm, Friday, 14'th Jan 2022 InvestorPlace
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Novavax still has not received EUA from the FDA as the market waits for approval. NVAX stock looks like a good buy here, especially if analysts'' revenue forecasts for 2022 come to pass as forecast. The post Novavax Still Has Not Received an FDA EUA as the Market Waits appeared first on InvestorPlace . More From InvestorPlace Stock Prodigy Who Found NIO at $2 Says Buy THIS Now Man Who Called Black Monday: Prepare Now. #1 EV Stock Still Flying Under the Radar Interested in Crypto? Read This First
NVAX Stock Alert: Why Is Novavax Plunging Today?
04:02pm, Friday, 14'th Jan 2022 InvestorPlace
With the vaccine mandate failing to pass, companies like Novavax face an uncertain future. Here''s why bears are circling NVAX stock.
Thinking about buying stock in China SXT Pharmaceuticals, Virgin Galactic, Citigroup, Novavax, or Spectrum Pharmaceuticals?
03:30pm, Friday, 14'th Jan 2022 Benzinga
NEW YORK , Jan. 14, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for SXTC, SPCE, C, NVAX, and SPPI. Full story available on Benzinga.com
Moderna and Novavax extend losses after Supreme Court strikes down Biden''s vaccine mandate for private employers
02:15pm, Friday, 14'th Jan 2022 Business Insider Markets
The vaccine mandate was aimed at private companies with more than 100 employees. The ruling upheld a mandate for healthcare workers.
COVID-19 vaccine makers in the red as officials question need for Omicron-specific shots
01:32pm, Friday, 14'th Jan 2022 Seeking Alpha
Leading COVID-19 vaccine makers Pfizer (PFE)/BioNTech (BNTX), Moderna (MRNA), and Novavax (NVAX) are trading lower in the pre-market amid concerns that their efforts to
Moderna, Novavax, Standard Lithium among premarket losers'' pack
01:17pm, Friday, 14'th Jan 2022 Seeking Alpha
BTCS (BTCS) -10%.Novavax (NVAX) -10%.Standard Lithium (SLI) -7%.Singularity Future Technology (SGLY) -6%.Orchid Island Capital ORC -6% after dividend cut due to margin
Dogecoin, Citigroup, Novavax, Las Vegas Sands: What to Watch When the Stock Market Opens Today
11:55am, Friday, 14'th Jan 2022 The Wall Street Journal
Tesla made some of its merchandise available for purchase with dogecoin; Major bank earnings are rolling in.
NVAX Stock: One Big Reason Novavax Is Stumbling Today
07:19pm, Thursday, 13'th Jan 2022 InvestorPlace
Today, some commentary from Novavax''s CEO has investors in NVAX stock re-thinking the bull thesis behind this Covid-19 vaccine play.
Novavax Stock Bulls Face an Uphill Challenge
06:52pm, Thursday, 13'th Jan 2022 InvestorPlace
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Off and on the price chart, Novavax investors need to be concerned with a mischievous Wall Street bearishly pricing in the news in NVAX stock. The post Novavax Stock Bulls Face an Uphill Challenge appeared first on InvestorPlace . More From InvestorPlace Stock Prodigy Who Found NIO at $2 Says Buy THIS Now Man Who Called Black Monday: Prepare Now. #1 EV Stock Still Flying Under the Radar Interested in Crypto? Read This First
Novavax Stock Still Has A Solid Chance
08:35pm, Wednesday, 12'th Jan 2022 InvestorPlace
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Novavax has a lot to look forward to with a surge in Covid-19 cases and a consistent rise in the demand for boosters. Buy NVAX stock. The post Novavax Stock Still Has A Solid Chance appeared first on InvestorPlace . More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS Now Man Who Called Black Monday: “Prepare Now.” #1 EV Stock Still Flying Under the Radar Interested in Crypto? Read This First…
Novavax COVID-19 vaccine could be cleared in multiple countries in 90 days: CEO Stanley Erck
10:04am, Tuesday, 11'th Jan 2022 Seeking Alpha
On Monday, Stanley Erck, the CEO of Novavax (NVAX) said he expects the company''s coronavirus vaccine could be cleared for use in multiple countries, including U.S., in coming months
Novavax, Inc. (NVAX) CEO Stanley Erck Presents at 40th Annual J.P. Morgan Healthcare Conference (Transcript)
10:08pm, Monday, 10'th Jan 2022 Seeking Alpha
Serum Institute Seeks Emergency Use Approval Of Covid Vaccine Covovax In South Africa
09:48pm, Monday, 10'th Jan 2022 NDTV
Novavax and Serum Institute of India (SII) announced a regulatory submission to the South African Health Products Regulatory Agency for emergency use authorization (EUA) of Novavax'' recombinant nanoparticle protein-based COVID-19 vaccine
Gilead CEO: Oral Version Of Covid Drug Remdesivir In Early Testing
06:21pm, Monday, 10'th Jan 2022 ValueWalk
Following are excerpts from CNBC interviews with Gilead Sciences, Inc. (NASDAQ:GILD) Chairman & CEO Daniel ODay and Novavax, Inc. (NASDAQ:NVAX) President & CEO Stanley Erck on CNBCs Squawk on the Street (M-F 9AM 11AM ET) today, Monday, January 10th. Following is a link to video on CNBC.com: Q4 2021 hedge fund letters, conferences and []
